Development of a Protocol for using Steroids after Cataract Surgery

Phase 4

• Conditions: Phacoemulsification; Inflammation; E04.540.825.249

• Registration Number: RBR-2frpntv
• Lead Sponsor: Instituto para o Desenvolvimento da Educação Ltda-IPADE/Faculdade

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-11-16
• Last Update Posted: 29 May 2023
• Study Completion: 2023-10-31

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients with cataracts; Over 18 years old; Patients from Instituto Cearense de Oftalmologia cataracts department; Patients who do not have other eye conditions that cause eye inflammation, increased intraocular pressure, decreased visual acuity and macular edema, including diabetic retinopathy; Patients who accepted to participate the study signed the informed consent form.

Exclusion Criteria

Ocular affections which cause inflammation, elevated intraocular pressure, reduced vision acuity and macular edema; Allergy to corticosteroids; Any condition that could interfere to the correct use of the eye drops, including patient's social and/or economic situation; Use of any eye drops, except lubricants
Ocular or systemic use of Non-steroidal anti-inflammatory drugs, corticosteroids, immunosuppressives or anti-histaminics 2 days before to 21 days after the surgery

Study & Design

• Study Type: Intervention
• Study Design: Not specified